The Midlife Transition, Depression, and Its Clinical Management Journal Articles

abstract

• The World Health Organization estimates that more than 260 million people are affected by depression worldwide, a condition that imposes a significant burden to individuals, their families, and society. Women seem to be disproportionately more affected by depression than men, and it is now clear that some women may experience windows of vulnerability for depression at certain reproductive stages across their life span, including the midlife transition. For some, age, the presence of cardiovascular or metabolic problems, and the emergence of significant, bothersome vasomotor symptoms and sleep problems may result in a compounded, deleterious impact on well-being and overall functioning.

authors

• Soares, Claudio N
• Shea, Alison

status

• published 

publication date

• March 2021

has subject area

• 1114 Paediatrics and Reproductive Medicine (FoR)
• Antidepressive Agents (MeSH)
• Anxiety (MeSH)
• Cognition (MeSH)
• Cognitive Behavioral Therapy (MeSH)
• Depression (MeSH)
• Depressive Disorder, Major (MeSH)
• Estrogens (MeSH)
• Female (MeSH)
• Hot Flashes (MeSH)
• Humans (MeSH)
• Life Change Events (MeSH)
• Menopause (MeSH)
• Middle Aged (MeSH)
• Obstetrics & Reproductive Medicine (Science Metrix)
• Prevalence (MeSH)
• Quality of Life (MeSH)
• Risk Factors (MeSH)
• Sleep (MeSH)

published in

• Obstetrics and Gynecology Clinics of North America  Journal

keywords

• Antidepressive Agents
• Anxiety
• Cognition
• Cognitive Behavioral Therapy
• Depression
• Depressive Disorder, Major
• Estrogen therapy
• Estrogens
• Female
• Hot Flashes
• Humans
• Life Change Events
• Menopause
• Middle Aged
• Midlife transition
• Nonhormonal interventions
• Prevalence
• Quality of Life
• Risk Factors
• Sleep

Digital Object Identifier (DOI)

• 10.1016/j.ogc.2020.11.009

PubMed ID

• 33573787

start page

• 215

end page

• 229

volume

• 48

issue

• 1